Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
09 2021
Historique:
revised: 01 06 2021
received: 23 03 2021
accepted: 07 06 2021
pubmed: 24 6 2021
medline: 11 11 2021
entrez: 23 6 2021
Statut: ppublish

Résumé

It is recommended to assess frailty prior to heart transplantation (HT). Our objective was to assess the prevalence of frailty in patients listed for HT. The FELICITAR registry (Frailty Evaluation after List Inclusion, Characteristics and Influence on TrAnsplantation And Results) is a prospective registry that includes patients listed for HT in three centers, from January 2017 to April 2019. We assessed the presence of frailty, depression, cognitive impairment, and quality of life when included. Ninety-nine patients were included. Of this group, 30.6% were frail, 55 (56.1%) had depression (treated only in nine patients), and 51 (54.8%) had cognitive impairment. Compared with non-frail patients, frail patients were more frequently hospitalized when included in HT waiting list (P = .048), had a lower upper-arm circumference (P = .026), had a lower Barthel index (P = .001), more anemia (P = .010), higher rates of depression (P = .001), poorer quality of life (P = .001), and lower hand-grip strength (P < .001). In multivariate analysis hand-grip strength (odds ratio .91; 95% confidence interval .87-.96, P < .001) and Barthel index (odds ratio .90; 95% confidence interval .82-.99, P = .024) were associated with frailty. Frailty, depression, and cognitive impairment are common in patients included in HT waiting list. Frailty is strongly associated with hand-grip strength.

Identifiants

pubmed: 34159629
doi: 10.1111/ctr.14391
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14391

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol. 2009;103:1616-1621.
Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci. 2009;64:675-681.
Formiga F, Vidán MT, Ariza-Solé A, Martínez-Sellés M. Reflections on the importance of frailty in the assessment of cardiovascular risk in the elderly. Rev Esp Cardiol. 2016;69:1008-1010.
Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18:869-875.
Anker S. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683-693.
Joseph SM, Rich MW. Targeting frailty in heart failure. Curr Treat Options Cardiovasc Med. 2017;19:31.
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35:1-23.
Kobashigawa J, Shah P, Joseph S, et al. Frailty in heart transplantation: report from the heart workgroup of a consensus conference on frailty. Am J Transplant. 2021;21:636-644.
Seese L, Hirji S, Sultan I, Gleason T, Kilic A. A frailty screening tool for patients undergoing orthotopic heart transplant. Ann Thorac Surg. 2020;2:S0003-497531103-6.
Ayesta A, Astiz MTV, Masa MJV, Segovia J, Cosío MDG, Martínez-Sellés M. Rationale and design of the FELICITAR registry (Frailty Evaluation After List Inclusion, Characteristics and Influence on Transplantation and Results). Clin Cardiol. 2018;41:293-299.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-56.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94.
Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med. 2001;63:679-686.
Nasreddine ZS, Phillips NA, BéDirian V©R, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
Garin O, Soriano N, Ribera A, et al. Validation of the Spanish version of the Minnesota living with heart failure questionnaire. Rev Esp Cardiol. 2008;61:251-259.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Med State Med J. 1965;14:61-65.
Rockwood K, Howlett SE, Macknight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004;59:1310-1317.
Díez-Villanueva P, Arizá-Solé A, Vidán MT, et al. Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de fragilidad en el anciano con cardiopatía. Rev Esp Cardiol. 2019;72:63-71.
Jha SR, Hannu MK, Chang S, et al. The Prevalence and prognostic significance of frailty in patients with advanced heart failure referred for heart transplantation. Transplantation. 2016;100:429-436.
Cacciatore F, Amarelli C, Maiello C, et al. Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty. ESC Heart Fail. 2020;7:757-762.
Chung CJ, Wu C, Jones M, et al. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail. 2014;20:310-315.
Panchangam C, White DA, Goudar S, et al. Translation of the frailty paradigm from older adults to children with cardiac disease. Pediatr Cardiol. 2020;41:1031-1041.
Vitale C, Jankowska E, Hill L, et al. Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure. Eur J Heart Fail. 2019;21:1299-1305.
Valentova M, Von Haehling S, Krause C, et al. Cardiac cachexia is associated with right ventricular failure and liver dysfunction. Int J Cardiol. 2013;169:219-224.
Scherbakov N, Doehner W. Heart-brain interactions in heart failure. Cardiac Failure Rev. 2018;4:87-91.
Lupón J, González B, Santaeugenia S, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol. 2008;61:835-842.
Dew MA, Rosenberger EM, Myaskovsky L, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis. Transplantation. 2015;100:988-1003.
Delibasic M, Mohamedali B, Dobrilovic N, Raman J. Pre-transplant depression as a predictor of adherence and morbidities after orthotopic heart transplantation. J Cardiothorac Surg. 2017;12:62.
Okwuosa I, Pumphrey D, Puthumana J, Brown R-M, Cotts W. Impact of identification and treatment of depression in heart transplant recipients. Cardiovasc Psychiatry Neurol. 2014;2014:747293.
Peters LL, Ambardekar AV, Rosenthal LD, Mcilvennan CK. Universal depression screen of ambulatory heart transplant recipients with referral for mental health intervention: a quality improvement project. J Nurs Care Qual. 2021;36:236-241.
Cacciatore F, Amarelli C, Maiello C, et al. Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure. J Affect Disord. 2020;272:132-137.
Jha SR, Hannu MK, Gore K, et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation. J Heart Lung Transplant. 2016;35:1092-1100.
Uchmanowicz I, Gobbens RJj. The relationship between frailty, anxiety and depression, and health-related quality of life in elderly patients with heart failure. Clin Interv Aging. 2015;10:1595-1600.
à Vila-Funes J©A, Amieva Hã©Lã¨Ne, Barberger-Gateau P, et al. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc. 2009;57:453-461.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752-762.

Auteurs

Ana Ayesta (A)

Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

María Jesús Valero Masa (MJ)

Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Universidad Complutense, Madrid, Spain.

María Teresa Vidán (MT)

Universidad Complutense, Madrid, Spain.
Servicio de Geriatría, Hospital General Universitario Gregorio Marañón, CIBERFES, Madrid, Spain.

Raquel Luna-López (R)

Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.

Javier Segovia-Cubero (J)

Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

María Dolores García-Cosío (MD)

Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.

Laura Pérez Gómez (L)

Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

Pedro Caravaca Pérez (PC)

Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.

Jorge Vázquez López-Ibor (J)

Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

Jorge Nuche (J)

Universidad Complutense, Madrid, Spain.
Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Manuel Martínez-Sellés (M)

Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Madrid, Spain.
Universidad Complutense, Madrid, Spain.
Servicio de Cardiología, Universidad Europea, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH